The Army Drug Testing Process: A Soldier’s Guide to Urinalysis

From the moment a Soldier is directed to provide a sample to the point results reach the command, every step of the Army urinalysis process is governed by binding regulatory requirements. Those requirements exist to prevent substitution, dilution, adulteration, and documentation failures — and to ensure the results that drive personnel decisions can withstand scrutiny. Unit collection personnel are responsible for controlling the testing environment, confirming each Soldier’s identity, and safeguarding every specimen from collection through shipment to the laboratory.

Two primary DoD instructions govern the technical side of this process: DoDI 1010.16 controls collection methods and chain-of-custody requirements, while DoDI 1010.10 establishes the overarching DoD drug testing program structure. The Army implements both through AR 600-85, its Substance Abuse Program regulation.

This guide covers how the Army urinalysis collection process is structured, what makes a test legally valid, how chain-of-custody requirements operate, and what a positive result actually sets in motion.

Every Urinalysis Must Rest on a Lawful Test Basis

The Army is not authorized to collect urine on a whim. Every urinalysis must be tied to a recognized lawful basis before a Soldier can be directed to provide a specimen. Army and DoD policy identify several accepted categories, including:

• Random inspection testing under the unit inspection program
• Unit sweep inspections
• Pre-accession or initial entry testing
• Consent testing
• Probable cause testing
• Command-directed or medically authorized testing, where regulation permits

DoDI 1010.10 requires commanders to administer drug testing programs under proper authority and within defined categories. AR 600-85 governs how the Army applies those categories and how commanders are expected to respond once results are received.

Chain of Custody: The Foundation of a Valid Result

The reliability of any Army urinalysis rests on chain-of-custody discipline. Units document every stage of specimen handling on DD Form 2624 (Specimen Custody Document — Drug Testing). Under DoDI 1010.16, custody must remain unbroken and all required paperwork must be completed from collection through receipt at the laboratory.

Specimen integrity is protected through direct observation. DoDI 1010.16 mandates collection under strict procedures, including direct observation by a same-sex observer who witnesses the urine leave the body and enter the collection bottle — eliminating any opportunity for substitution or tampering.

In operational terms:

• Every handoff of the specimen must be tracked and recorded
• All required signatures must appear on the custody form
• The unit holds the specimen secure until it is transferred to the laboratory
• Any missing entry or gap in documented custody creates risk to the credibility and admissibility of the result

A chain-of-custody break can generate serious legal problems even when the laboratory chemistry is otherwise conclusive.

DoD-Certified Laboratories Process All Army Specimens

Army specimens are shipped to DoD-certified forensic drug testing laboratories that operate under standardized methods, cutoff levels, confirmation protocols, and reporting requirements. DoDI 1010.10 sets the program structure; DoDI 1010.16 controls the technical handling and testing procedures those labs must follow.

DoD laboratory certification standardizes:

• Screening and confirmation testing methods
• Cutoff thresholds that determine when a result is reported as positive
• Retesting rules and procedures
• Reporting formats submitted to commands
• Specimen retention requirements

What a Positive Result Actually Triggers

A confirmed positive urinalysis does not resolve the matter — it opens the command and legal process. AR 600-85 governs how commanders respond to confirmed positive results; DoDI 1010.10 sets the broader DoD requirements for program reliability and oversight.

A Positive Result Does Not Automatically Establish Wrongful Use

Article 112a of the UCMJ criminalizes wrongful use of controlled substances. Wrongful use requires both knowledge and the absence of lawful authorization. A laboratory result can support an inference of knowing use — but that inference is not automatic, it does not apply in every case, and it is rebuttable.

Defenses that arise in contested cases include:

• Unknowing ingestion
• Documented prescription or lawful medical authorization
• Contamination or specimen handling irregularities
• Collection defects that undermine the result’s reliability

The command’s ultimate decision depends on the evidence as a whole — the test basis, the procedural record, and the surrounding circumstances — not the lab report alone.

Substances Tested and DoD Confirmatory Cutoff Levels

A DoD-certified laboratory reports a positive only when a specimen meets the confirmatory cutoff thresholds established in DoDI 1010.16. The DoD core panel cutoffs are:

• Cannabinoid metabolites (Marijuana): 15 ng/mL
• Cocaine metabolites: 100 ng/mL
• Amphetamine / Methamphetamine: 100 ng/mL
• Designer amphetamines (MDMA/MDA): 500 ng/mL
• Heroin metabolite (6-AM): 10 ng/mL
• Hydrocodone: 100 ng/mL
• Hydromorphone: 100 ng/mL
• Codeine / Morphine: 2,000 ng/mL
• Oxycodone: 100 ng/mL
• Oxymorphone: 100 ng/mL
• Benzodiazepines: 100 ng/mL
• Fentanyl / Norfentanyl: 1.0 ng/mL

Labs may also test a percentage of specimens — or units may request additional testing — for substances such as LSD or synthetic cannabinoids, as authorized under DoDI 1010.16.

Retesting: What Is Permitted and What It Cannot Fix

Retesting is available under defined conditions, but Soldiers should not assume it will occur automatically. DoDI 1010.16 authorizes retesting only when sufficient specimen volume remains and the request is submitted through proper channels following required procedures.

Time is a critical factor. Once the laboratory has depleted or destroyed the specimen under its retention schedule, retesting is no longer possible.

A retest can confirm or fail to confirm the originally reported result. What it cannot do is remedy:

• Observer failures during collection
• Gaps or errors in chain-of-custody documentation
• Handling, labeling, or identification mistakes
• Test basis coding errors or authorization deficiencies

Procedural defects are independent of chemistry. Retesting the specimen does not cure them.

A Soldier’s Rights Following a Positive Result

A confirmed positive result can trigger UCMJ action, administrative separation, and the loss of substantial benefits. It is not a bureaucratic formality. Soldiers retain the right to remain silent and the right to consult with legal counsel.

Action should be taken immediately upon notification:

• Invoke the right to remain silent — do not make statements about drug use to anyone before consulting counsel.
• Request legal counsel without delay — before the command takes further action.
• Engage counsel early enough to identify and preserve defenses, including procedural defects in the collection record.

An attorney experienced in military drug cases can examine every component of the record: the stated test basis, chain-of-custody documentation, observer compliance, and the laboratory file.

Common Collection Defects in Army Urinalysis Cases

Many of the most contested Army urinalysis cases turn not on the lab result but on how the specimen was collected and handled. DoDI 1010.16 imposes standardized collection requirements to ensure reliability, and failures to meet those requirements can directly affect both admissibility and evidentiary weight.

Defects identified in contested cases include:

• Observer failures — the observer does not maintain continuous direct observation as required
• Chain-of-custody gaps or missing entries on DD Form 2624
• Identity verification or bottle control failures during the collection event
• Test basis coding errors that do not accurately reflect the authority under which the collection occurred
• Handling, storage, or shipment irregularities that create questions about specimen integrity

These defects do not automatically result in dismissal. However, they can meaningfully influence command decisions, separation outcomes, and evidentiary use in both court-martial proceedings and administrative separation boards.

Final Thoughts

The Army urinalysis program functions as both a readiness tool and an accountability mechanism — but it also carries significant legal consequences for individual Soldiers. The integrity of the process depends on a lawful test basis, strict observation procedures, fully documented chain of custody on DD Form 2624, and compliance with the technical standards set by DoD. Gaps in any of those areas create room to challenge the result.

If you are facing a positive urinalysis result, consult with an experienced military defense attorney as early as possible. The record that matters most is often assembled — or lost — in the days immediately following notification.

Governing Authorities

• DoDI 1010.10 — Military Personnel Drug Abuse Testing Program (MPDATP)
• DoDI 1010.16 — Technical Procedures for the MPDATP
• AR 600-85 — The Army Substance Abuse Program (ASAP)